dalteparin has been researched along with Ascites in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Ascites: Accumulation or retention of free fluid within the peritoneal cavity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marin, L | 1 |
| Vitagliano, A | 1 |
| Capobianco, G | 1 |
| Dessole, F | 1 |
| Ambrosini, G | 1 |
| Andrisani, A | 1 |
1 other study available for dalteparin and Ascites
| Article | Year |
|---|---|
Which is the optimal timing for starting chemoprotection with gonadotropin-releasing hormone agonists after oocyte cryopreservation? Reflections on a critical case of ovarian hyperstimulation syndrome.
Topics: Adult; Anticoagulants; Antineoplastic Agents, Hormonal; Ascites; Cryopreservation; Cryoprotective Ag | 2021 |